CJC-1295 (No DAC) + Ipamorelin Blend 10mg
CJC-1295 (No DAC) combined with Ipamorelin is a dual-peptide blend studied in laboratory environments for its interaction with growth hormone-related signalling pathways. This combination is commonly utilised in controlled research settings to explore peptide synergy, receptor activity, and endocrine response mechanisms.
Apex Peptides supplies this 5mg blend in a high-purity, lyophilised format, designed to ensure stability, accuracy, and consistency across experimental applications. Each batch is manufactured under strict quality-controlled conditions, supporting reliable and repeatable outcomes in professional research environments.
Key Features
- ≥99% purity (HPLC tested)
- 10mg combined peptide blend
- CJC-1295 (No DAC) + Ipamorelin formulation
- Lyophilised powder for enhanced stability
- Suitable for endocrine and receptor-based research
Product Specifications
- Peptides: CJC-1295 (No DAC) + Ipamorelin
- Quantity: 10mg
- Purity: ≥99% (HPLC)
- Form: Lyophilised powder
- Structure: Dual-peptide blend
- Storage: Store at 2–8°C, protected from light and moisture
Intended Use
This product is supplied strictly for laboratory research purposes. Intended for in vitro use in controlled scientific environments by qualified professionals.
Compliance & Safety Notice
This compound is not intended for human or animal consumption and must not be used for therapeutic, diagnostic, cosmetic, or food-related purposes.
By purchasing, you confirm that you are a qualified researcher or authorised to act on behalf of a licensed research facility, and that all use complies with applicable regulations. No claims are made regarding safety, efficacy, or intended outcomes.
FAQ's
These are some of the most commonly asked questions we get. If you have a question, please go through these first before reaching out - more than likely the questions has already been answered!
Have a question?
info@apexpeptides.com.au
Our average response time is 24 hours.